Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment ...
ImmunityBio IBRX stock: jumped 31% Wednesday after the EU approved ANKTIVA for bladder cancer, now authorized in 33 countries with a 71% clinical response rate.
Deion Sanders and Karrueche Tran open up about their relationship during his bladder cancer battle and the emotional decision he offered her.
Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...
Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small ...
Studies show durvalumab can halt progression of the muscle-invasive form of the disease and prevent further hospitalisation.
Discover why your pregnant belly feels hard sometimes and soft other times. Learn trimester-by-trimester changes, Braxton Hicks signs, and when to call your doctor immediately.
Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical ...
The artist on her Tate Modern exhibition, her recovery from bladder cancer, and the work she'd never make today ...
Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
1 Department of Urology, The People’s Hospital of Leshan, Leshan, China 2 Department of Urology, Affiliated Hospital of Yunnan University (Second People’s Hospital of Yunnan Province, Ophthalmic ...